The Risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) and Worsening Diabetic Retinopathy (DR) with Semaglutide
Varsha Narayanan & Naresh Purohit · Asian Journal of Research and Reports in Ophthalmology · 2025
Semaglutide, a GLP-1RA (receptor agonist), is being increasingly used for type 2 diabetes mellitus (T2DM) and weight management, broadening its clinical reach. While there has been a rapidly expanding scope, market, and exposed population for semaglutide, there have also been gro...
Open access
Research Article
10.9734/ajrrop/2025/v8i1124